A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC
Public ClinicalTrials.gov record NCT03927703. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy and Safety of SB206 and Vehicle Gel Once Daily in the Treatment of Molluscum Contagiosum
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 3 multi-center, randomized, double-blind, vehicle-controlled, parallel group study to be conducted in up to approximately 340 subjects ≥6 months of age with MC. Subjects or their caregivers will apply SB206 12% or Vehicle Gel once daily for a minimum of 4 weeks and up to 12 weeks to all lesions identified at Baseline and new treatable lesions that arise during the course of the study.
Study identification
- NCT ID
- NCT03927703
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 355 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Months and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 13, 2019 (Actual)
- Primary completion
- Nov 11, 2019 (Actual)
- Completion
- Feb 3, 2020 (Actual)
- Last update posted
- Mar 23, 2023
2019 – 2020
United States locations
- U.S. sites
- 27
- U.S. states
- 21
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site #266 | Scottsdale | Arizona | 85255 | — |
| Site #101 | Hot Springs | Arkansas | 71913 | — |
| Site #282 | Beverly Hills | California | 90212 | — |
| Site #113 | San Diego | California | 92123 | — |
| Site #257 | Thornton | Colorado | 80233 | — |
| Site #268 | Boynton Beach | Florida | 33437 | — |
| Site #292 | DeLand | Florida | 32720 | — |
| Site #278 | Miami | Florida | 33175 | — |
| Site #305 | Tampa | Florida | 33613 | — |
| Site #175 | New Albany | Indiana | 47150 | — |
| Site #294 | Owensboro | Kentucky | 42301 | — |
| Site #289 | Metairie | Louisiana | 70006 | — |
| Site #297 | New Orleans | Louisiana | 70124 | — |
| Site #275 | Largo | Maryland | 20774 | — |
| Site #274 | Clarkston | Michigan | 48346 | — |
| Site #121 | Fridley | Minnesota | 55448 | — |
| Site #206 | Omaha | Nebraska | 68144 | — |
| Site #304 | Portsmouth | New Hampshire | 03801 | — |
| Site #201 | Berlin | New Jersey | 08009 | — |
| Site #108 | Rochester | New York | 14623 | — |
| Site #309 | Portland | Oregon | 97223 | — |
| Site #255 | Mt. Pleasant | South Carolina | 29464 | — |
| Site #271 | Knoxville | Tennessee | 37938 | — |
| Site #167 | Houston | Texas | 77030 | — |
| Site #293 | Plano | Texas | 75024 | — |
| Site #281 | Syracuse | Utah | 84075 | — |
| Site #267 | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03927703, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2023 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03927703 live on ClinicalTrials.gov.